Julius C. Heemelaar
Articles
-
Aug 8, 2023 |
jamanetwork.com | Tomas G. Neilan |Hannah Gilman |Amanda Smith |Julius C. Heemelaar
Key PointsQuestion Does 1 year of treatment with atorvastatin, 40 mg/d, started prior to anthracycline-based chemotherapy among patients with lymphoma, reduce the chance of a significant decrease in left ventricular ejection fraction (LVEF) compared with placebo?
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →